Potent anaplastic lymphoma kinase (ALK) inhibitor (IC50 = 3.5 nM). Also inhibits Ack and ROS1 activity (IC50 values are 5.8 and 8.9 nM respectively). Attenuates proliferation, and induces apoptosis of NPM-ALK+ T cell anaplastic large-cell lymphoma (ALCL) cells in vitro. Suppresses tumor growth of NPM-ALK+ ALCL cell xenografts in mice. Causes tumor shrinkage in hEML4-ALK transgenic mice. Orally available.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 580.74. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.2 mM||8.61 mL||43.05 mL||86.1 mL|
|1 mM||1.72 mL||8.61 mL||17.22 mL|
|2 mM||0.86 mL||4.3 mL||8.61 mL|
|10 mM||0.17 mL||0.86 mL||1.72 mL|
References are publications that support the biological activity of the product.
George et al (2014) The ALK inhibitor ASP3026 eradicates NPM-ALK+ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. Oncotarget 5 5750 PMID: 25026277
Awad and Shaw (2014) ALK Inhibitors in Non-Small Cell Lung Cancer: Crizotinib and Beyond. Clin.Adv.Hematol.Oncol. 12 429 PMID: 25322323
Mori et al (2014) The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice. Mol.Cancer Ther. 13 329 PMID: 24419060
If you know of a relevant reference for ASP 3026, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: ASP 3026, ASP 3026 supplier, ASP3026, potent, alk, inhibitors, inhibits, anaplastic, lymphoma, kinases, tyrosine, ack, ros1, crizotinib, npm-alk, non-small, cell, lung, cancer, antitumor, TNK2, kinase, non-receptor, 2, ALK, Ack1, 5310, Tocris Bioscience
Citations for ASP 3026
Citations are publications that use Tocris products.
Currently there are no citations for ASP 3026. Do you know of a great paper that uses ASP 3026 from Tocris? Please let us know.
Reviews for ASP 3026
There are currently no reviews for this product. Be the first to review ASP 3026 and earn rewards!
Have you used ASP 3026?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.